Gainers
- SenesTech (NASDAQ:SNES) shares moved upwards by 11.1% to $4.11 during Tuesday's after-market session. SenesTech's trading volume hit 206.4K shares by close, accounting for 177.0% of its average volume over the last 100 days. The company's market cap stands at $2.7 million.
- Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 6.71% to $0.59. The market value of their outstanding shares is at $8.9 million.
- Aspira Womens Health (NASDAQ:AWH) shares moved upwards by 5.26% to $0.6. The company's market cap stands at $74.7 million.
- Predictive Oncology (NASDAQ:POAI) shares moved upwards by 4.99% to $0.58. The company's market cap stands at $45.4 million.
- Dyne Therapeutics (NASDAQ:DYN) shares moved upwards by 4.98% to $14.75. Dyne Therapeutics's trading volume hit 216.7K shares by close, accounting for 70.8% of its average volume over the last 100 days. The company's market cap stands at $768.8 million.
- Immix Biopharma (NASDAQ:IMMX) shares rose 4.87% to $3.01. The company's market cap stands at $41.9 million.
Losers
- Lixte Biotech Hldgs (NASDAQ:LIXT) shares fell 10.6% to $1.69 during Tuesday's after-market session. Trading volume for this security closed at 1.0 million, accounting for 2183.3% of its average full-day volume over the last 100 days. The company's market cap stands at $28.1 million.
- Evolus (NASDAQ:EOLS) stock decreased by 8.11% to $8.5. The market value of their outstanding shares is at $478.0 million.
- Celyad Oncology (NASDAQ:CYAD) stock declined by 8.01% to $1.38. At the close, Celyad Oncology's trading volume reached 3.0 million shares. This is 210.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
- Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock declined by 7.49% to $2.1. This security traded at a volume of 98.1K shares come close, making up 17.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $19.9 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) stock fell 7.27% to $0.43. The company's market cap stands at $38.5 million.
- Processa Pharma (NASDAQ:PCSA) stock declined by 7.08% to $0.81. The company's market cap stands at $12.9 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.